Pharmafile Logo

Impetus Digital official statement on COVID-19

At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their attendance for in-person meetings and ask to dial in remotely instead. This is a good thing, as evidence shows that social distancing will be key to flatten the curve and slow the spread of COVID-19.

We are big advocates for both public health and maintaining a viable economy. Therefore, we are strongly encouraging our clients to transfer their upcoming in-person meetings to virtual ones, either using synchronous web meetings, asynchronous touchpoints, or both. This is particularly relevant for large groups or if traveling is required, especially since many international travel restrictions are currently being enforced.

To do our part in keeping the population and economy healthy in these uncertain times, Impetus will waive cancellation fees for any new virtual consultancy, working group, medical education, or internal team meeting that is planned with us. This way, you can rest assured that if you need to quickly set up a virtual meeting in lieu of an in-person meeting, you will not be charged if you need to cancel it for whatever reason.

For more information on our different options for virtual meetings, please visit our website www.impetusdigital.com or make an appointment with Natalie Yeadon at www.meetwithnatalie.com to discuss your needs.

We are always respectfully here to serve our clients, especially during this time of tumult and uncertainty.

Stay safe and healthy,

The Impetus Team

This content was provided by Impetus Digital

Documents for download:

Company Details

 Latest Content from  Impetus Digital 

Advancing the Scientific Understanding of Medical Cannabis Through Real-Time User Data

David Berg, President and CTO of Strainprint, explores the current state of the medical cannabis industry in Canada and overseas and how Strainprint is bringing innovation to the industry. He...

Advancing Precision Medicine in Oncology

Jerome Madison, Host of The Precision Medicine Podcast, shares his leadership lessons and tips for building and training new sales teams in the era of precision medicine. He also dives...

Wearable Technologies for Detecting Pre-Symptomatic Illness and Infections

Dr. Tejaswini Mishra, Research Scientist at Stanford University School of Medicine, dives into her research on using wearable technologies for detecting COVID-19 and other diseases before patients become symptomatic. Among...

Search Listening as a Tool to Inform Brand Strategy & Enable Patient-Centricity

Julia Walsh, CEO of Brand Medicine International, explores the concept of “search listening” in healthcare, and how it can be used to inform brand strategy, improve patient-centricity, and fight scientific...

Top 10 Tips for Running a Successful Virtual Event

Based on 13 years of experience in virtualizing life science meetings and events

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Leading Successful Change Through Innovative Digital Technologies

Cassie Solomon, CEO of The New Group Consulting, dives into the future of innovation, digital technologies, and systems thinking in healthcare. Among many other things, we discuss how organizations can prepare...

Alternative Approaches to Personalized Medicine in Oncology

Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how...

Reimagining Healthcare Using Mobile Health Technologies

Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into...